Form 4 Tracker
Hims & Hers Health, Inc.
HIMS

54 insider filings · Latest: Jun 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Oct 7, 2024Oct 7 9:33 PMMelissa Baird
Proposed Sale
58,750$19.44$1.1M

View →

Oct 1, 2024Oct 1 6:35 PMBoughton Soleil
Proposed Sale
2,339$18.50$43.3K

View →

Sep 20, 2024Sep 20 8:34 PMAndrew Dudum
Proposed Sale
687,498$16.92$11.6M

View →

Sep 17, 2024Sep 17 4:38 PMBoughton Soleil
Proposed Sale
2,339$16.50$38.6K

View →

Sep 17, 2024Sep 17 2:59 PMBecklund Irene
Proposed Sale
10,017$16.50$165.3K

View →

Sep 17, 2024Sep 17 2:57 PMChi Michael
Proposed Sale
25,550$16.50$421.6K

View →

Sep 16, 2024Sep 16 2:53 PMBecklund Irene
Proposed Sale
472$16.45$7.8K

View →

Sep 5, 2024Sep 5 9:22 PMMelissa Baird
Proposed Sale
11,749$14.43$169.5K

View →

Sep 4, 2024Sep 4 10:27 PMMelissa Baird
Proposed Sale
11,749$14.61$171.7K

View →

Sep 3, 2024Sep 3 9:18 PMOluyemi Okupe
Proposed Sale
371,177$14.50$5.4M

View →

Sep 3, 2024Sep 3 9:18 PMMelissa Baird
Proposed Sale
11,884$14.50$172.3K

View →

Sep 3, 2024Sep 3 9:18 PMAndrew Dudum
Proposed Sale
333,332$14.50$4.8M

View →

Sep 3, 2024Sep 3 4:13 PMBoughton Soleil
Proposed Sale
2,345$14.65$34.4K

View →

Aug 27, 2024Aug 27 3:09 PMPendarvis Christiane
Proposed Sale
7,000$15.15$106.1K

View →

Nov 6, 2024Carroll Patrick Harrison
Proposed Sale
15,000$22.07$331.1K

View →

← Previous

Page 9 of 9

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 11, 2026Jun 15 9:12 PMDelos M. CosgroveDirector
Option Exercise
3,6560(D)

View →

May 20, 2026May 22 8:16 PMPatrick Harrison CarrollDirector, Chief Medical Officer
Grant/Award
435435(D)

View →

May 20, 2026May 22 8:16 PMChristopher D PayneDirector
Grant/Award
647647(D)

View →

May 20, 2026May 22 8:16 PMDavid B WellsDirector
Grant/Award
957957(D)

View →

May 18, 2026May 19 11:39 PMOluyemi OkupeChief Financial Officer
Option Exercise
7,950$5.01115,900(D)

View →

Apr 20, 2026Apr 22 9:24 PMOluyemi OkupeChief Financial Officer
Option Exercise
12,553$11.5335,996(D)

View →

Apr 17, 2026Apr 20 8:38 PMOluyemi OkupeChief Financial Officer
Option Exercise
6,184$5.01129,403(D)

View →

Apr 6, 2026Apr 7 9:14 PMOluyemi OkupeChief Financial Officer
Option Exercise
3,975$5.01135,587(D)

View →

Mar 20, 2026Mar 24 10:09 PMOluyemi OkupeChief Financial Officer
Option Exercise
4,489$5.01139,562(D)

View →

Mar 13, 2026Mar 17 8:29 PMMichael ChiChief Operating Officer
Option Exercise
72,108127,191(D)

View →

Mar 13, 2026Mar 17 8:29 PMChristiane PendarvisDirector
Option Exercise
15,2110(D)

View →

Mar 13, 2026Mar 17 8:29 PMPatrick Harrison CarrollDirector, Chief Medical Officer
Option Exercise
16,52242,397(D)

View →

Mar 13, 2026Mar 17 8:29 PMDeborah M. AutorDirector, Chief Policy Officer
Option Exercise
32,919493,792(D)

View →

Mar 13, 2026Mar 17 8:29 PMIrene BecklundPAO
Option Exercise
17,98716,714(D)

View →

Mar 13, 2026Mar 17 8:28 PMAndrew DudumDirector, Chief Executive Officer, 10% Owner
Option Exercise
164,369229,805(D)

View →

Mar 13, 2026Mar 17 8:28 PMSoleil BoughtonChief Legal Officer
Option Exercise
41,42174,194(D)

View →

Mar 13, 2026Mar 17 8:28 PMOluyemi OkupeChief Financial Officer
Option Exercise
105,200137,790(D)

View →

Mar 11, 2026Mar 13 8:20 PMIrene BecklundPAO
Grant/Award
62,07662,076(D)

View →

Mar 11, 2026Mar 13 8:20 PMMichael ChiChief Operating Officer
Grant/Award
376,222376,222(D)

View →

Mar 11, 2026Mar 13 8:20 PMDeborah M. AutorDirector, Chief Policy Officer
Grant/Award
526,711526,711(D)

View →